Position in KYTX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$36,763,720
+$1,155,314 QoQ
Shares Held
4,126,119
0.0% QoQ
Ownership
6.67%
of shares outstanding
% of Portfolio
2.23%
of 13F equity value
Holder Rank
#2
of 120 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GILEAD SCIENCES, INC. holds $1,649,480,361 across 5 Biotechnology names. KYTX ranks #4 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RCUS |
Arcus Biosciences, Inc.
|
31,424,760 | $968,825,350 | |
| 2 | LKFT |
Lakefront Biotherapeutics NV
|
16,707,477 | $500,890,160 | |
| 3 | ASMB |
Assembly Biosciences, Inc.
|
4,977,089 | $136,770,405 | |
| 4 | KYTX |
Kyverna Therapeutics, Inc.
This page
|
4,126,119 | $36,763,720 | |
| 5 | XLO |
Xilio Therapeutics, Inc.
|
650,389 | $6,230,726 |
All Filings in KYTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,763,720 | 4,126,119 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $35,608,406 | 4,126,119 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $38,785,518 | 4,126,119 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $24,756,714 | 4,126,119 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,667,185 | 4,126,119 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,963,409 | 4,126,119 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $15,431,685 | 4,126,119 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||